Codes / ICD10CM / M1A.1411

M1A.1411 Lead-induced chronic gout, right hand, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Right Hand, with Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the right hand and includes the presence of tophi (urate crystal deposits), resulting in persistent symptoms and potential tissue damage if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Over time, urate crystals deposit in tissues, forming tophi. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults

Symptoms

  • Recurrent episodes of intense joint pain in the right hand
  • Persistent swelling, redness, and warmth in the affected area
  • Formation of tophi (hard, painless lumps) under the skin of the right hand
  • Stiffness and limited right hand mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage, confirms the right hand as the affected site, and identifies tophi presence.

Treatment Options

  • Medications such as non-steroidal anti-inflammatory drugs (NSAIDs) or colchicine to manage pain and inflammation
  • Urate-lowering therapies (e.g., allopurinol) to reduce crystal formation
  • Local treatments for tophi, including drainage or surgical removal if necessary
  • Lead exposure reduction or removal from the environment

Prognosis and Follow-Up

With appropriate treatment, symptoms can be managed, and further joint damage may be prevented. Regular follow-up is essential to monitor uric acid levels, assess tophi progression, and adjust therapy. Untreated cases may lead to chronic joint damage or disability.

Complications

  • Chronic joint deformity or destruction in the right hand
  • Persistent pain and functional impairment
  • Increased risk of kidney stones or renal impairment due to uric acid buildup
  • Secondary infections of tophi if they ulcerate

Lifestyle & Prevention

  • Avoid or minimize lead exposure through occupational safety measures or environmental testing
  • Maintain a balanced diet low in purines to reduce uric acid production
  • Stay hydrated to support renal uric acid excretion
  • Follow prescribed medications consistently to control uric acid levels

When to Seek Professional Help

Seek medical attention if you experience severe or worsening right hand pain, swelling, or tophi growth, or if symptoms interfere with daily activities. Prompt evaluation is important to prevent permanent joint damage.

Tips for Medical Coders

Document the specific site (right hand) and the presence of tophi to accurately reflect the condition. Ensure clinical notes specify the affected hand and confirm tophi formation, as these details are critical for coding M1A.1411. Verify that lead exposure is documented as the underlying cause to support the diagnosis.

Book a walkthrough

M1A.1411 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.